Seminars in Oncology
Volume 33, Supplement 9 , Pages 24-28, June 2006

Use of Pemetrexed in Breast Cancer

  • Christian Dittrich

      Affiliations

    • Corresponding Author InformationAddress reprint requests to Prof Christian Dittrich, Ludwig Boltzmann-Institute for Applied Cancer Research, 3rd Medical Department - Center for Oncology and Hematology, Kaiser Franz Josef-Spital, Kundratstrasse 3, A-1100 Vienna, Austria.

Applied Cancer Research - Institution for Translational Research Vienna (ACR-ITR VIEnna), Vienna, Austria and Ludwig Boltzmann-Institute for Applied Cancer Research (LBI-ACR VIEnna), Kaiser Franz Josef-Spital, Vienna, Austria

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.

 Dr Dittrich has received honoraria from Eli Lilly and Company.

PII: S0093-7754(06)00137-0

doi:10.1053/j.seminoncol.2006.03.017

Seminars in Oncology
Volume 33, Supplement 9 , Pages 24-28, June 2006

Article Tools